SCHEMBL1711566

SCHEMBL1711566

N#CC(=Cc1ccccc1F)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
MITF O75030 1/20 0.46
HSP90AA1 P07900 1/20 0.46
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 3/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 2/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
APP P05067 1/20 0.38
SNCA P37840 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 4/20 0.37
ATM Q13315 1/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2191869 1.00 LMNA (0.46) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL1711146 0.83 MCL1 (0.55) LMNAALDH1A1KMT2AKDM4EPKM
SCHEMBL21457693 0.78 ADORA2A (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL7021269 0.78 ADORA2A (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL7021270 0.78 ADORA2A (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL801568 0.76 ALDH1A1 (0.54) HSP90AA1ALDH1A1KMT2AKDM4EPKM
SCHEMBL28436909 0.76 MCL1 (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL28897442 0.76 MCL1 (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL21457393 0.75 ALDH1A1 (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A
SCHEMBL21457396 0.75 ALDH1A1 (0.60) LMNAMITFHSP90AA1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150510-B2 Amino acid derivative NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-06 US disclosed
EP-2345635-A1 AMINO ACID DERIVATIVE Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2011-07-20 EP disclosed
US-20110172442-A1 AMINO ACID DERIVATIVE NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172442-A1 AMINO ACID DERIVATIVE OPRL1, OPRK1, SLC1A1 LMNA 4579/4885MITF 2828/4885HSP90AA1 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.